Form 4: Madrigal Pharmaceuticals Executive Carole Huntsman Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Carole Huntsman, Chief Commercial Officer of Madrigal Pharmaceuticals, sold 347 shares of common stock on January 24, 2025, to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On January 24, 2025, Carole Huntsman, the Chief Commercial Officer of Madrigal Pharmaceuticals, sold 347 shares of the company's common stock.
- The sale was executed at a price of $335.24 per share.
- This transaction was conducted to cover tax withholding obligations associated with the vesting of restricted stock units.
- Following the transaction, Huntsman directly owns 10,438 shares of Madrigal Pharmaceuticals' common stock.
Sentiment
Score: 6
Explanation: The document describes a routine transaction (sale of shares to cover taxes). It's neutral in sentiment as it doesn't reflect positively or negatively on the company's performance or outlook.
Management Comments
- The sale reported on this Form 4 represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units.
- This sale was automatic and not at the discretion of the Reporting Person.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and do not necessarily indicate a negative outlook on the company's future.
Stakeholder Impact
- The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the stated reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 01/24/2025 | Date of the stock sale transaction. |
| 01/27/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.